Hannah Brendan

CIK: 0001929422CBO, COO & CCO
Officer

Hannah Brendan is a corporate insider (CBO, COO & CCO) at Quince Therapeutics, Inc. (QNCX) filing SEC Form 4 transactions. 24 transactions, totaling $111,716 in purchases and $0 in sales. Source: SEC EDGAR.

Total Transactions
24
Total Buy Value
$112K
Total Sell Value
$0
Net Activity
+$112K
Last Transaction
Jan 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
365,000
Price
$3.08
Value
$1.12M
Type
Exercise
Shares
25,280
Price
-
Value
-
Type
Exercise
Shares
2,271
Price
-
Value
-
Type
Exercise
Shares
25,280
Price
$0.94
Value
$24K
Type
Exercise
Shares
2,271
Price
$0.55
Value
$1K
Type
Award
Shares
37,736
Price
$0.13
Value
$5K
Type
Award
Shares
37,736
Price
$1.20
Value
$45K
Type
Award
Shares
450,000
Price
$1.60
Value
$720K
Type
Purchase
Shares
23,565
Price
$0.63
Value
$15K
Type
Purchase
Shares
5,000
Price
$0.62
Value
$3K
Type
Purchase
Shares
2,280
Price
$0.61
Value
$1K
Type
Purchase
Shares
3,424
Price
$0.60
Value
$2K
Type
Purchase
Shares
2,500
Price
$0.61
Value
$2K
Type
Purchase
Shares
2,155
Price
$0.58
Value
$1K
Type
Exercise
Shares
56,061
Price
-
Value
-
Type
Exercise
Shares
56,061
Price
$0.55
Value
$31K
Type
Award
Shares
600,000
Price
-
Value
-
Type
Award
Shares
75,000
Price
$0.00
Value
$0
Type
Purchase
Shares
71,762
Price
$1.22
Value
$88K
Type
Award
Shares
225,000
Price
$0.00
Value
$0